A Study to Evaluate Reducing Stroke by Screening for Undiagnosed Atrial Fibrillation in Elderly Individuals

Overview

About this study

The purpose of this study is to determine if an atrial fibillation (AF) detection intervention in men and women at least 70 years of age with undiagnosed AF or atrial flutter (AFL) reduces the person-years incidence rate of stroke compared to usual care (no AF detection intervention).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Men and women, ≥ 70 years of age.
  • New or established patients in the primary care practice.
  • Willing to provide consent to participate in the study and to use personal health information to ascertain endpoints from the CMS Medicare Claims Database and to access data from health records.
  • Health insurance by Medicare Parts A & B (Medicare Fee-for-service).

Exclusion Criteria:

  • Oral anticoagulation (OAC) for any indication at the time of enrollment.
  • History of atrial fibrillation (AF) or atrial flutter (AFL) as documented in the patient’s current medical problem list.
  • Any condition the investigator considers a contraindication to OAC; e.g., bleeding that required medical attention or severe renal impairment.
  • Any condition the investigator considers will prevent compliance with study instructions.
  • Implanted cardiac devices (pacemakers, implantable cardiac defibrillators, or cardiac resynchronization therapy, and implantable loop recorders).
  • History of allergy to adhesive.
  • Patient is not able to wear the Zio®XT monitor or not able to apply the monitor by herself/himself or with the help of a caregiver

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

David Rushlow, M.D.

Closed for enrollment

Contact information:

Julie Maxson CCRP

(507) 266-0284

RSTFMSC@mayo.edu

Eau Claire, Wis.

Mayo Clinic principal investigator

Steven Rosas, M.D.

Closed for enrollment

Contact information:

Julie Maxson CCRP

(507) 266-0284

RSTFMSC@mayo.edu

La Crosse, Wis.

Mayo Clinic principal investigator

Jacob Erickson, D.O.

Closed for enrollment

Contact information:

Carolyn Flock B.S.

(608) 392-9462

Flock.Carolyn@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20502018

Mayo Clinic Footer